Phenazopyridine Hydrochloride
NDC 50696-003, Phenazopyridine Hydrochloride, tablet, from GPT Pharmaceuticals Private Limited.
- Product NDC
- 50696-003
- Status
- Listed
- Labeler
- GPT Pharmaceuticals Private Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50696-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE99.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50696-003-01 | 50696000301 | 25000 TABLET in 1 DRUM (50696-003-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50696-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50696-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50696-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.